Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans. (Q53568394)

15 May 2018

title

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans. (English)

1 reference

15 May 2018

1 reference

J H Choi

1

1 reference

15 May 2018

M G Lee

2

1 reference

15 May 2018

J-Y Cho

3

1 reference

15 May 2018

J-E Lee

4

1 reference

15 May 2018

K H Kim

5

1 reference

15 May 2018

K Park

6

1 reference

15 May 2018

language of work or name

English

0 references

publication date

13 June 2007

1 reference

15 May 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

15 May 2018

volume

83

1 reference

15 May 2018

page(s)

251-257

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Effects of fibrates on metabolism of statins in human hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

The effect of gemfibrozil on the pharmacokinetics of rosuvastatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Novel statins: pharmacological and clinical results.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Bile salt transporters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) and genetic variability (single nucleotide polymorphisms) in a hepatic drug uptake transporter: what's it all about?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Cost effectiveness of rosuvastatin in treating patients to low-density lipoprotein cholesterol goals compared with atorvastatin, pravastatin, and simvastatin (a US Analysis of the STELLAR Trial).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Safety of rosuvastatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100267

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100267

1 reference

15 May 2018

PubMed ID

17568401

1 reference

15 May 2018